No abstract available
MeSH terms
-
Aged
-
Alendronate / adverse effects
-
Alendronate / therapeutic use
-
Antibodies, Monoclonal, Humanized / administration & dosage
-
Antibodies, Monoclonal, Humanized / adverse effects*
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Bone Density Conservation Agents / administration & dosage
-
Bone Density Conservation Agents / adverse effects*
-
Bone Density Conservation Agents / therapeutic use
-
Denosumab
-
Drug Administration Schedule
-
Female
-
Femoral Fractures / chemically induced*
-
Femoral Fractures / diagnostic imaging
-
Fractures, Stress / chemically induced*
-
Fractures, Stress / diagnostic imaging
-
Humans
-
Osteoporosis, Postmenopausal / drug therapy
-
Osteoporotic Fractures / prevention & control
-
Radiography
Substances
-
Antibodies, Monoclonal, Humanized
-
Bone Density Conservation Agents
-
Denosumab
-
Alendronate